Viatris VTRS
NASDAQ VTRS
$17.60 +0.14 (+0.80%)
At close: Oct 2, 2026 · 4:00 PM EDT

Viatris (VTRS) Asset Writedowns and Impairment (2024 - 2025)

Updated

Viatris' Asset Writedowns and Impairment came in at $2.94 billion for FY2025, up 814.9% from $321 million in FY2024.

Analysis

Viatris (VTRS) Asset Writedowns and Impairment (2024 - 2025) Analysis & Trends

  • Per Business Quant, earlier years put Asset Writedowns and Impairment at $321 million in FY2024 (-44.7%) and $580.1 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Viatris 20.22 Bn 15.23 Bn 1.46 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 2.94 Bn
Jun 30, 2024 321.00 Mn
API Access

Viatris Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=VTRS&period=max&api_key=YOUR_API_KEY